SYDNEY, Dec. 12, 2022 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA) received a deficiency notification from the Listing Qualifications Staff of the Nasdaq Stock Market LLC, dated December […]

– A 92% SVR35 and a 67% TSS50 were Observed in the Efficacy Evaluable Patients at Week 24 – – 57% of Transfusion Independent Patients Achieved Hemoglobin Stabilization – – […]

HARTFORD, Conn., Dec. 12, 2022 /PRNewswire/ — Virtus Investment Partners, Inc. (NASDAQ: VRTS) today reported preliminary assets under management of $157.2 billion as of November 30, 2022. In addition, the […]

Provider of innovative training opportunities for the skilled trades selects top global B2B technology PR agency to drive awareness and growth KNOXVILLE, Tenn., Dec. 12, 2022 /PRNewswire/ — Interplay Learning, […]

VAUGHAN, ON, Dec. 12, 2022 /PRNewswire/ — Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live […]